Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase EARLY_PHASE1 1Phase 2 1

Status

Completed 3Terminated 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4Breast 3Other solid neoplasm 2Other hematologic neoplasm 2Lymphoid 2Plasma cell 1Other neoplasm 1Myeloid 1Dermatologic 1

Conditions

Colorectal Neoplasms 3Stomach Neoplasms 1Neoplasms 1Fatigue 1Colonic Neoplasms 1Breast Neoplasms 1

Interventions

Oxaliplatin 1413Fluorouracil 1301Capecitabine 1087Gemcitabine 1045Leucovorin 932Irinotecan 818Bevacizumab 804Cisplatin 669Radiotherapy 536Cetuximab 470pembrolizumab 428Paclitaxel 390Nivolumab 337130-nm albumin-bound paclitaxel 325Drug Therapy 314Docetaxel 287S 1 (combination) 274Sorafenib 266Folfox protocol 261Albumin-Bound Paclitaxel 259sintilimab 211durvalumab 210Surgical Procedures, Operative 204tislelizumab 203Radiosurgery 202lenvatinib 201apatinib 200Carboplatin 187Magnetic Resonance Spectroscopy 183regorafenib 181

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Asian ginseng × Gastrointestinal × Clear all
NCT06561516 2024-08-20

Effects of Red Ginseng on Gastrointestinal Symptoms and Microbiota After Surgery for Gastrointestinal Cancer

Gangnam Severance Hospital

Phase NA Completed
60 enrolled
Gastrointestinal

Stomach Neoplasms, Colorectal Neoplasms

NCT02581059 2024-06-26

Efficacy of Ginseng for Patients on Regorafenib

Wake Forest University Health Sciences

Phase 2 Terminated
10 enrolled 19 charts
Gastrointestinal

Fatigue, Colorectal Neoplasms

NCT03407716 2023-01-05

Ginseng in Decreasing Cancer-Related Fatigue After Treatment in Cancer Survivors

Mayo Clinic

Phase EARLY_PHASE1 Completed
2 enrolled
BreastGastrointestinal

Breast Neoplasms, Colonic Neoplasms

NCT02039635 2017-08-11

KRG

Korea Ginseng Corporation

Phase NA Completed
438 enrolled
Gastrointestinal

Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡